Ellen J. Kim, MD
Professor of Dermatology at the Hospital of the University of Pennsylvania
Attending Physician, Abramson Cancer Center, Hospital of the University of Pennsylvania
Director, Penn Cutaneous Lymphoma Program, Department of Dermatology, Hospital of the University of Pennsylvania
Vice Chair, Clinical Operations, Department of Dermatology, Hospital of the University of Pennsylvania
Department: Dermatology
Contact information
Department of Dermatology
Perelman School of Medicine at the University of Pennsylvania
Room 721, 7th Floor - South Tower
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Perelman School of Medicine at the University of Pennsylvania
Room 721, 7th Floor - South Tower
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-2737
Fax: 215-615-4966
Fax: 215-615-4966
Education:
A.B. (East Asian Studies)
Harvard University, 1991.
M.D.
University of Pennsylvania, 1996.
Permanent linkA.B. (East Asian Studies)
Harvard University, 1991.
M.D.
University of Pennsylvania, 1996.
Description of Research Expertise
Clinical trials for cutaneous T-cell lymphoma (CTCL)Description of Clinical Expertise
Cutaneous Lymphomas (T-cell and B-cell) and lymphoproliferative disordersGraft vs Host Disease
Extracorporeal Photopheresis
Selected Publications
Hardin J, Cohen L, Rook AH, Kim EJ.: Evaluating Photopheresis Regimens for advanced CTCL: The role of the SARS COV2 pandemic, a single center review. Dermatologic Therapy 2023 (in press).Polgione B, Alexander-Savino CV, Kim EJ, Mangold AR, Desimone J, Wong H, Rumage AT, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH.: HyBryte™ Use in Early-Stage Cutaneous T-cell Lymphoma Frontiers Drug Discovery 2023 (in press).
Chairatchaneeboon M and Kim EJ: Parapsoriasis. Fitzpatrick's Therapeutics: a clinician's guide to dermatologic treatment. Kang S, Goh CL, Kim N, Kwatra S (eds.). McGraw-Hill LLC, 2023.
Chairatchaneeboon M and Kim EJ: Pityriasis lichenoides et varioliformis acuta (PLEVA). Fitzpatrick's Therapeutics: a clinician's guide to dermatologic treatment. McGraw-Hill LLC (eds.). 2023.
Villasenor-Park J and Kim EJ: Sezary Syndrome. Fitzpatrick's Therapeutics: a clinician's guide to dermatologic treatment. Kang S, Goh CL, Kim N, Kwatra S (eds.). McGraw Hill LLC, 2023.
Himeles JM, Holton J, Samimi S, Vittorio C, Rook AH, Haun P, Villasenor-Park J, Kim EJ. : Paying the Price of Cutaneous T-cell Lymphoma: Recent trends in skin directed and self-administered systemic Cutaneous T-cell Lymphoma treatment costs in the United States. J Am Acad Dermatol Page: S0190-9622(22)02251-4. Epub ahead of print. July 2022 Notes: doi: 10.1016/j.jaad.2022.06.1200.
Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. : Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 158(9): 1031-1039, Sep 2022 Notes: doi: 10.1001/jamadermatol.2022.2749.
Weiner DM, Lewis DJ, Spaccarelli NG, Clark RA, Nasta SD, Loren AW, Rook AH, Kim EJ.: Management of Relapsed Cutaneous T-Cell Lymphoma Following Allogeneic Hematopoietic Stem Cell Transplantation: Review with Representative Patient Case. Dermatologic Therapy Page: DOI: 10.1111/dth.15538, April 2022.
Weiner DM, Clark AK, Bhansali RS, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS.: Usage and safety of topical tacrolimus in patients with mycosis fungoides. Clin Exp Dermatol. Mar 4 2022.
Olsen E, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim Y, Wood G, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papdavid E, Quaglino P, Pittelkow M, Prince H, Sanches J, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. : Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC Blood Nov 2021.